Recovery of feline leukaemia virus from non-viraemic cats
- PMID: 6304986
- DOI: 10.1136/vr.112.15.339
Recovery of feline leukaemia virus from non-viraemic cats
Abstract
The persistence of virus in the bone marrow of cats which had ostensibly recovered from feline leukaemia virus (FeLV) infection was investigated. Nineteen cats were exposed to FeLV by natural, contact infection and 36 weeks later three were found to be persistently viraemic while the remainder were non-viraemic and had virus neutralising serum antibodies. Virus was isolated in bone marrow cultures established from nine of the 16 non-viraemic cats which were considered, therefore, to have latent infections. Cats infected soon after exposure to FeLV carrier cats were more likely to become persistently viraemic or develop a latent infection than those infected later, which tended to recover. There was no difference in serum antibody levels between the latently infected and recovered cats. Whether cats with latent infections spread virus or develop FeLV-negative haemopoietic tumours was considered. Six kittens housed together for eight months with a cat with a latent infection showed no signs of having been exposed to FeLV. Virus was not isolated from bone marrow cultures of two cats with FeLV-free lymphosarcoma or myelomonocytic leukaemia.
Similar articles
-
Transmission of feline leukaemia virus in the milk of a non-viraemic cat.Vet Rec. 1986 Apr 5;118(14):381-4. doi: 10.1136/vr.118.14.381. Vet Rec. 1986. PMID: 3012849
-
Feline leukaemia vaccine protection against viral latency.Vaccine. 1987 Jun;5(2):133-5. doi: 10.1016/0264-410x(87)90060-0. Vaccine. 1987. PMID: 3037814
-
A comparison of three methods of feline leukaemia virus diagnosis.Vet Rec. 1982 Apr 3;110(14):325-8. doi: 10.1136/vr.110.14.325. Vet Rec. 1982. PMID: 6281960
-
[Feline leukemia virus (FeLV) and FeLV-associated diseases in cats: a review].Tijdschr Diergeneeskd. 1987 Jun 15;112(12):726-37. Tijdschr Diergeneeskd. 1987. PMID: 3039686 Review. Dutch.
-
Control of feline leukaemia virus.Vet Immunol Immunopathol. 1989 May;21(1):69-83. doi: 10.1016/0165-2427(89)90131-1. Vet Immunol Immunopathol. 1989. PMID: 2549695 Review.
Cited by
-
A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus.Vaccine. 2005 May 31;23(29):3814-23. doi: 10.1016/j.vaccine.2005.02.026. Epub 2005 Mar 16. Vaccine. 2005. PMID: 15893619 Free PMC article.
-
Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.J Virol. 2001 Sep;75(18):8424-33. doi: 10.1128/jvi.75.18.8424-8433.2001. J Virol. 2001. PMID: 11507187 Free PMC article.
-
A feline large granular lymphoma and its derived cell line.In Vitro Cell Dev Biol. 1990 May;26(5):455-63. doi: 10.1007/BF02624087. In Vitro Cell Dev Biol. 1990. PMID: 2161827
-
Haematological disorders associated with feline retrovirus infections.Baillieres Clin Haematol. 1995 Mar;8(1):73-112. doi: 10.1016/s0950-3536(05)80233-1. Baillieres Clin Haematol. 1995. PMID: 7663052 Free PMC article. Review.
-
Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma.Retrovirology. 2010 Feb 19;7:14. doi: 10.1186/1742-4690-7-14. Retrovirology. 2010. PMID: 20167134 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous